AEON Biopharma, Inc. (AEON) Operating cash flow 2021–2025
AEON Biopharma, Inc. (AEON) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$17.3MFY2025 · since FY2021: -$1.5M → -$17.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.3M | +14.7% |
| FY2024 | -$20.3M | — |
| FY2022 | -$35.6M | -2280.5% |
| FY2021 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice